December 2021 FDA Recall Drug by Teva Pharmaceuticals Usa
D-0294-2022 - Subpotent

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on December 16, 2021 for the product Drug. The FDA reported the reason for recall as subpotent. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0294-2022

Reason for Recall
Subpotent
Initiated
12-16-2021
Reported
12-29-2021
Quantity
a) 86,790 and b) 25,416 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL (NDC 00093-4125-74) (when mixed) bottles, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454

Batch or Lot Expiration Information

Lot# a) Lots, 35446365A, Exp 03/2022; 35447040A, Exp 08/2022 & 35447948B, Exp 03/2023. b) Lots 35446318B, Exp 05/2022 & 35447947A, Exp 03/2023.